Clarifications on Technologies to Optimize Care of Severe COVID-19 Patients
- PMID: 32665462
- PMCID: PMC7365583
- DOI: 10.1213/ANE.0000000000005120
Clarifications on Technologies to Optimize Care of Severe COVID-19 Patients
Conflict of interest statement
Conflicts of Interest: S.J.B. has intellectual property assigned to Mayo Clinic (Rochester, MN); has received research funding from Merck & Co, Inc (funds to Mayo Clinic) and is a consultant for Merck & Co, Inc (Kenilworth, NJ); is a principal and shareholder in Senzime AB (publ) (Uppsala, Sweden); and a member of the Scientific Advisory Boards for The Doctors Company (Napa, CA) and NMD Pharma (Aarhus, Denmark).
Comment in
-
In Response.Anesth Analg. 2020 Oct;131(4):e193-e195. doi: 10.1213/ANE.0000000000005121. Anesth Analg. 2020. PMID: 32665463 Free PMC article. No abstract available.
Comment on
-
Technologies to Optimize the Care of Severe COVID-19 Patients for Health Care Providers Challenged by Limited Resources.Anesth Analg. 2020 Aug;131(2):351-364. doi: 10.1213/ANE.0000000000004985. Anesth Analg. 2020. PMID: 32433248 Free PMC article. Review.
References
-
- Naguib M, Brull SJ, Johnson KB. Conceptual and technical insights into the basis of neuromuscular monitoring. Anaesthesia. 2017;72(suppl 1):16–37. - PubMed
-
- Donati F. Neuromuscular monitoring: more than meets the eye. Anesthesiology. 2012;117:934–936. - PubMed
-
- Naguib M, Brewer L, LaPierre C, Kopman AF, Johnson KB. The myth of rescue reversal in “can’t intubate, can’t ventilate” scenarios. Anesth Analg. 2016;123:82–92. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources